Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84


Correlation between quantified breast densities from digital mammography and 18F-FDG PET uptake.

Lakhani P, Maidment AD, Weinstein SP, Kung JW, Alavi A.

Breast J. 2009 Jul-Aug;15(4):339-47. doi: 10.1111/j.1524-4741.2009.00737.x.


Relationship between 18F-FDG uptake and breast density in women with normal breast tissue.

Vranjesevic D, Schiepers C, Silverman DH, Quon A, Villalpando J, Dahlbom M, Phelps ME, Czernin J.

J Nucl Med. 2003 Aug;44(8):1238-42.


The effect of age, menopausal state, and breast density on (18)F-FDG uptake in normal glandular breast tissue.

Mavi A, Cermik TF, Urhan M, Puskulcu H, Basu S, Cucchiara AJ, Yu JQ, Alavi A.

J Nucl Med. 2010 Mar;51(3):347-52. doi: 10.2967/jnumed.109.068718. Epub 2010 Feb 11.


Background ¹⁸F-FDG uptake in positron emission mammography (PEM): correlation with mammographic density and background parenchymal enhancement in breast MRI.

Koo HR, Moon WK, Chun IK, Eo JS, Jeyanth JX, Chang JM, Cho N, Kang KW.

Eur J Radiol. 2013 Oct;82(10):1738-42. doi: 10.1016/j.ejrad.2013.05.016. Epub 2013 Jun 24.


Standardized uptake value and quantification of metabolism for breast cancer imaging with FDG and L-[1-11C]tyrosine PET.

Kole AC, Nieweg OE, Pruim J, Paans AM, Plukker JT, Hoekstra HJ, Schraffordt Koops H, Vaalburg W.

J Nucl Med. 1997 May;38(5):692-6.


Potential of dual-time-point imaging to improve breast cancer diagnosis with (18)F-FDG PET.

Kumar R, Loving VA, Chauhan A, Zhuang H, Mitchell S, Alavi A.

J Nucl Med. 2005 Nov;46(11):1819-24.


SUV varies with time after injection in (18)F-FDG PET of breast cancer: characterization and method to adjust for time differences.

Beaulieu S, Kinahan P, Tseng J, Dunnwald LK, Schubert EK, Pham P, Lewellen B, Mankoff DA.

J Nucl Med. 2003 Jul;44(7):1044-50.


Standardized uptake values of uterine leiomyoma with 18F-FDG PET/CT: variation with age, size, degeneration, and contrast enhancement on MRI.

Kitajima K, Murakami K, Yamasaki E, Kaji Y, Sugimura K.

Ann Nucl Med. 2008 Jul;22(6):505-12. doi: 10.1007/s12149-008-0135-2. Epub 2008 Aug 1.


Impact of breast density on computer-aided detection for breast cancer.

Brem RF, Hoffmeister JW, Rapelyea JA, Zisman G, Mohtashemi K, Jindal G, Disimio MP, Rogers SK.

AJR Am J Roentgenol. 2005 Feb;184(2):439-44. Erratum in: AJR Am J Roentgenol. 2005 Jun;184(6):1968.


Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer.

Ueda S, Tsuda H, Asakawa H, Shigekawa T, Fukatsu K, Kondo N, Yamamoto M, Hama Y, Tamura K, Ishida J, Abe Y, Mochizuki H.

Jpn J Clin Oncol. 2008 Apr;38(4):250-8. doi: 10.1093/jjco/hyn019.


Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results.

Heusch P, Buchbender C, Köhler J, Nensa F, Beiderwellen K, Kühl H, Lanzman RS, Wittsack HJ, Gomez B, Gauler T, Schuler M, Forsting M, Bockisch A, Antoch G, Heusner TA.

Rofo. 2013 Nov;185(11):1056-62. doi: 10.1055/s-0033-1350110. Epub 2013 Jul 16.


Regional 2-[18F]fluoro-2-deoxy-D-glucose uptake varies in normal lung.

Miyauchi T, Wahl RL.

Eur J Nucl Med. 1996 May;23(5):517-23.


Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.

Avril N, Menzel M, Dose J, Schelling M, Weber W, Jänicke F, Nathrath W, Schwaiger M.

J Nucl Med. 2001 Jan;42(1):9-16.


Breast cancer staging in a single session: whole-body PET/CT mammography.

Heusner TA, Kuemmel S, Umutlu L, Koeninger A, Freudenberg LS, Hauth EA, Kimmig KR, Forsting M, Bockisch A, Antoch G.

J Nucl Med. 2008 Aug;49(8):1215-22. doi: 10.2967/jnumed.108.052050. Epub 2008 Jul 16.


Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Service Task Force [Internet].

Melnikow J, Fenton JJ, Whitlock EP, Miglioretti DL, Weyrich MS, Thompson JH, Shah K.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Jan.


Time course of tumor SUV in 18F-FDG PET of breast cancer: presentation of a simple model using a single reference point for time corrections of tumor SUVs.

Stahl AR, Heusner TA, Hartung V, Nagarajah J, Bockisch A, Hahn S, Antoch G, Jentzen W.

J Nucl Med. 2011 Jan;52(1):18-23. doi: 10.2967/jnumed.110.077461. Epub 2010 Dec 13.


Dynamic and static approaches to quantifying 18F-FDG uptake for measuring cancer response to therapy, including the effect of granulocyte CSF.

Doot RK, Dunnwald LK, Schubert EK, Muzi M, Peterson LM, Kinahan PE, Kurland BF, Mankoff DA.

J Nucl Med. 2007 Jun;48(6):920-5. Epub 2007 May 15.


Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer.

Dose-Schwarz J, Tiling R, Avril-Sassen S, Mahner S, Lebeau A, Weber C, Schwaiger M, Jänicke F, Untch M, Avril N.

Br J Cancer. 2010 Jan 5;102(1):35-41. doi: 10.1038/sj.bjc.6605427. Epub 2009 Nov 17.


Diagnostic accuracy of digital versus film mammography: exploratory analysis of selected population subgroups in DMIST.

Pisano ED, Hendrick RE, Yaffe MJ, Baum JK, Acharyya S, Cormack JB, Hanna LA, Conant EF, Fajardo LL, Bassett LW, D'Orsi CJ, Jong RA, Rebner M, Tosteson AN, Gatsonis CA; DMIST Investigators Group..

Radiology. 2008 Feb;246(2):376-83. doi: 10.1148/radiol.2461070200.

Supplemental Content

Support Center